Isovalent
Business/Productivity Software
Current Valuation
N/A
As of September 7, 2022
Total Funding Raised
N/A
Across 2 rounds
Last Round
Later Stage VC (Series B)
$40.0M
Last Funding
Sep 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Interested in buying or selling Isovalent shares?
Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| September 7, 2022 | Later Stage VC (Series B) | $40.0M | N/A | - |
| November 10, 2020 | Early Stage VC (Series A) | $29.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Isovalent is currently valued at N/A as of September 7, 2022.
What is Isovalent Worth in 2026?
Isovalent is a leading private company in the Business/Productivity Software sector. Track Isovalent's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Isovalent Valuation is Determined
Private company valuations like Isovalent's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.